Last Price
30.25
Today's Change
+0.075 (0.24%)
Day's Change
30.03 - 31.53
Trading Volume
70,882
Market Cap
974 Million
Shares Outstanding
32 Million
Avg Volume
378,425
Avg Price (50 Days)
36.66
Avg Price (200 Days)
35.50
PE Ratio
12.91
EPS
2.34
Earnings Announcement
20-Feb-2025
Previous Close
30.18
Open
30.48
Day's Range
30.034 - 31.53
Year Range
24.606 - 42.287
Trading Volume
71,290
1 Day Change
0.13%
5 Day Change
-8.48%
1 Month Change
-20.47%
3 Month Change
-11.90%
6 Month Change
-9.22%
Ytd Change
-3.23%
1 Year Change
20.35%
3 Year Change
51.02%
5 Year Change
65.23%
10 Year Change
145.89%
Max Change
145.89%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.